APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hormone Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hormone Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchHormone Disorder Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hormone Disorder Drug Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Hormone Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hormone Disorder Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hormone Disorder Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Hormone Disorder Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hormone Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hormone Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hormone Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hormone Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hormone Disorder Drug include Abbott, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Sanofi, Novartis AG, Merck KGaA, Lilly, Ferring B.V and PT. Daewoong Pharmaceutical Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hormone Disorder Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hormone Disorder Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hormone Disorder Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hormone Disorder Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Hormone Disorder Drug Segment by Company

Abbott

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Sanofi

Novartis AG

Merck KGaA

Lilly

Ferring B.V

PT. Daewoong Pharmaceutical Company

Mayne Pharma Group Limited

Ipsen Pharma

Genentech, Inc

F. Hoffmann-La Roche Ltd

Bausch Health Companies Inc

Amneal Pharmaceutical Inc

Hormone Disorder Drug Segment by Type

Growth Hormone Stimulator

Growth Hormone Inhibitor

Hormone Disorder Drug Segment by Application

Dwarfism

Gigantism

Other

Hormone Disorder Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormone Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hormone Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormone Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hormone Disorder Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hormone Disorder Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hormone Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hormone Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hormone Disorder Drug Industry Trends Table 2. Hormone Disorder Drug Industry Drivers Table 3. Hormone Disorder Drug Industry Opportunities and Challenges Table 4. Hormone Disorder Drug Industry Restraints Table 5. Global Hormone Disorder Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hormone Disorder Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hormone Disorder Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hormone Disorder Drug Sales Market Share by Manufacturers Table 9. Global Hormone Disorder Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hormone Disorder Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hormone Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hormone Disorder Drug Manufacturers, Product Type & Application Table 13. Global Hormone Disorder Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hormone Disorder Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Growth Hormone Stimulator Table 17. Major Manufacturers of Growth Hormone Inhibitor Table 18. Global Hormone Disorder Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Hormone Disorder Drug Sales by Type (2021-2026) & (k units) Table 20. Global Hormone Disorder Drug Sales by Type (2027-2032) & (k units) Table 21. Global Hormone Disorder Drug Sales Market Share by Type (2021-2026) Table 22. Global Hormone Disorder Drug Sales Market Share by Type (2027-2032) Table 23. Global Hormone Disorder Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Hormone Disorder Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Hormone Disorder Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Hormone Disorder Drug Revenue Market Share by Type (2021-2026) Table 27. Global Hormone Disorder Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Dwarfism Table 29. Major Manufacturers of Gigantism Table 30. Major Manufacturers of Other Table 31. Global Hormone Disorder Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Hormone Disorder Drug Sales by Application (2021-2026) & (k units) Table 33. Global Hormone Disorder Drug Sales by Application (2027-2032) & (k units) Table 34. Global Hormone Disorder Drug Sales Market Share by Application (2021-2026) Table 35. Global Hormone Disorder Drug Sales Market Share by Application (2027-2032) Table 36. Global Hormone Disorder Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Hormone Disorder Drug Revenue by Application (2021-2026) & (k units) Table 38. Global Hormone Disorder Drug Revenue by Application (2027-2032) & (k units) Table 39. Global Hormone Disorder Drug Revenue Market Share by Application (2021-2026) Table 40. Global Hormone Disorder Drug Revenue Market Share by Application (2027-2032) Table 41. Global Hormone Disorder Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Hormone Disorder Drug Sales by Region (2021-2026) & (k units) Table 43. Global Hormone Disorder Drug Sales Market Share by Region (2021-2026) Table 44. Global Hormone Disorder Drug Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Hormone Disorder Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 48. North America Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 49. Europe Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 51. Europe Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Hormone Disorder Drug Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Hormone Disorder Drug Sales by Country (2027-2032) & (k units) Table 58. Global Hormone Disorder Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hormone Disorder Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hormone Disorder Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hormone Disorder Drug Revenue Market Share by Region (2021-2026) Table 62. Global Hormone Disorder Drug Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Hormone Disorder Drug Product Portfolio Table 67. Abbott Recent Development Table 68. Teva Pharmaceutical Industries Ltd Company Information Table 69. Teva Pharmaceutical Industries Ltd Business Overview Table 70. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio Table 72. Teva Pharmaceutical Industries Ltd Recent Development Table 73. Sun Pharmaceutical Industries Ltd Company Information Table 74. Sun Pharmaceutical Industries Ltd Business Overview Table 75. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio Table 77. Sun Pharmaceutical Industries Ltd Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sanofi Hormone Disorder Drug Product Portfolio Table 82. Sanofi Recent Development Table 83. Novartis AG Company Information Table 84. Novartis AG Business Overview Table 85. Novartis AG Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis AG Hormone Disorder Drug Product Portfolio Table 87. Novartis AG Recent Development Table 88. Merck KGaA Company Information Table 89. Merck KGaA Business Overview Table 90. Merck KGaA Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merck KGaA Hormone Disorder Drug Product Portfolio Table 92. Merck KGaA Recent Development Table 93. Lilly Company Information Table 94. Lilly Business Overview Table 95. Lilly Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lilly Hormone Disorder Drug Product Portfolio Table 97. Lilly Recent Development Table 98. Ferring B.V Company Information Table 99. Ferring B.V Business Overview Table 100. Ferring B.V Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Ferring B.V Hormone Disorder Drug Product Portfolio Table 102. Ferring B.V Recent Development Table 103. PT. Daewoong Pharmaceutical Company Company Information Table 104. PT. Daewoong Pharmaceutical Company Business Overview Table 105. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Portfolio Table 107. PT. Daewoong Pharmaceutical Company Recent Development Table 108. Mayne Pharma Group Limited Company Information Table 109. Mayne Pharma Group Limited Business Overview Table 110. Mayne Pharma Group Limited Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Mayne Pharma Group Limited Hormone Disorder Drug Product Portfolio Table 112. Mayne Pharma Group Limited Recent Development Table 113. Ipsen Pharma Company Information Table 114. Ipsen Pharma Business Overview Table 115. Ipsen Pharma Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Ipsen Pharma Hormone Disorder Drug Product Portfolio Table 117. Ipsen Pharma Recent Development Table 118. Genentech, Inc Company Information Table 119. Genentech, Inc Business Overview Table 120. Genentech, Inc Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Genentech, Inc Hormone Disorder Drug Product Portfolio Table 122. Genentech, Inc Recent Development Table 123. F. Hoffmann-La Roche Ltd Company Information Table 124. F. Hoffmann-La Roche Ltd Business Overview Table 125. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Portfolio Table 127. F. Hoffmann-La Roche Ltd Recent Development Table 128. Bausch Health Companies Inc Company Information Table 129. Bausch Health Companies Inc Business Overview Table 130. Bausch Health Companies Inc Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bausch Health Companies Inc Hormone Disorder Drug Product Portfolio Table 132. Bausch Health Companies Inc Recent Development Table 133. Amneal Pharmaceutical Inc Company Information Table 134. Amneal Pharmaceutical Inc Business Overview Table 135. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Amneal Pharmaceutical Inc Hormone Disorder Drug Product Portfolio Table 137. Amneal Pharmaceutical Inc Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Hormone Disorder Drug Distributors List Table 141. Hormone Disorder Drug Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Hormone Disorder Drug Product Image Figure 2. Global Hormone Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hormone Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Hormone Disorder Drug Sales (2021-2032) & (k units) Figure 5. Global Hormone Disorder Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hormone Disorder Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Growth Hormone Stimulator Image Figure 9. Growth Hormone Inhibitor Image Figure 10. Global Hormone Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Hormone Disorder Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hormone Disorder Drug Sales Market Share by Type (2021-2032) Figure 13. Global Hormone Disorder Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hormone Disorder Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hormone Disorder Drug Revenue Market Share by Type (2021-2032) Figure 16. Dwarfism Image Figure 17. Gigantism Image Figure 18. Other Image Figure 19. Global Hormone Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Hormone Disorder Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hormone Disorder Drug Sales Market Share by Application (2021-2032) Figure 22. Global Hormone Disorder Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Hormone Disorder Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hormone Disorder Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Hormone Disorder Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Hormone Disorder Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Hormone Disorder Drug Sales Market Share by Country (2021-2032) Figure 39. China Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Hormone Disorder Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Hormone Disorder Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Hormone Disorder Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hormone Disorder Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hormone Disorder Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hormone Disorder Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hormone Disorder Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Growth Hormone Stimulator
  • Growth Hormone Inhibitor
Applications
  • Dwarfism
  • Gigantism
  • Other
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Novartis AG
  • Merck KGaA
  • Lilly
  • Ferring B.V
  • PT. Daewoong Pharmaceutical Company
  • Mayne Pharma Group Limited
  • Ipsen Pharma
  • Genentech, Inc
  • F. Hoffmann-La Roche Ltd
  • Bausch Health Companies Inc
  • Amneal Pharmaceutical Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hormone Disorder Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hormone Disorder Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hormone Disorder Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hormone Disorder Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hormone Disorder Drug Market Dynamics
  1. 2.1 Hormone Disorder Drug Industry Trends
  2. 2.2 Hormone Disorder Drug Industry Drivers
  3. 2.3 Hormone Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Hormone Disorder Drug Industry Restraints
3 Hormone Disorder Drug Market by Manufacturers
  1. 3.1 Global Hormone Disorder Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hormone Disorder Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hormone Disorder Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hormone Disorder Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hormone Disorder Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hormone Disorder Drug Manufacturers, Product Type & Application
  7. 3.7 Global Hormone Disorder Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hormone Disorder Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hormone Disorder Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hormone Disorder Drug Tier 1, Tier 2, and Tier 3
4 Hormone Disorder Drug Market by Type
  1. 4.1 Hormone Disorder Drug Type Introduction
  2. 4.1.1 Growth Hormone Stimulator
  3. 4.1.2 Growth Hormone Inhibitor
  4. 4.2 Global Hormone Disorder Drug Sales by Type
  5. 4.2.1 Global Hormone Disorder Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hormone Disorder Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Hormone Disorder Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hormone Disorder Drug Revenue by Type
  9. 4.3.1 Global Hormone Disorder Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hormone Disorder Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Hormone Disorder Drug Revenue Market Share by Type (2021-2032)
5 Hormone Disorder Drug Market by Application
  1. 5.1 Hormone Disorder Drug Application Introduction
  2. 5.1.1 Dwarfism
  3. 5.1.2 Gigantism
  4. 5.1.3 Other
  5. 5.2 Global Hormone Disorder Drug Sales by Application
  6. 5.2.1 Global Hormone Disorder Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hormone Disorder Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Hormone Disorder Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hormone Disorder Drug Revenue by Application
  10. 5.3.1 Global Hormone Disorder Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hormone Disorder Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Hormone Disorder Drug Revenue Market Share by Application (2021-2032)
6 Global Hormone Disorder Drug Sales by Region
  1. 6.1 Global Hormone Disorder Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hormone Disorder Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Hormone Disorder Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Hormone Disorder Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hormone Disorder Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hormone Disorder Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hormone Disorder Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hormone Disorder Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hormone Disorder Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hormone Disorder Drug Revenue by Region
  1. 7.1 Global Hormone Disorder Drug Revenue by Region
  2. 7.1.1 Global Hormone Disorder Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hormone Disorder Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Hormone Disorder Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Hormone Disorder Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hormone Disorder Drug Revenue (2021-2032)
  8. 7.2.2 North America Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hormone Disorder Drug Revenue (2021-2032)
  11. 7.3.2 Europe Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hormone Disorder Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hormone Disorder Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hormone Disorder Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Hormone Disorder Drug Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Teva Pharmaceutical Industries Ltd
  8. 8.2.1 Teva Pharmaceutical Industries Ltd Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Ltd Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
  13. 8.3 Sun Pharmaceutical Industries Ltd
  14. 8.3.1 Sun Pharmaceutical Industries Ltd Company Information
  15. 8.3.2 Sun Pharmaceutical Industries Ltd Business Overview
  16. 8.3.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Industries Ltd Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Hormone Disorder Drug Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Novartis AG
  26. 8.5.1 Novartis AG Company Information
  27. 8.5.2 Novartis AG Business Overview
  28. 8.5.3 Novartis AG Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis AG Hormone Disorder Drug Product Portfolio
  30. 8.5.5 Novartis AG Recent Developments
  31. 8.6 Merck KGaA
  32. 8.6.1 Merck KGaA Company Information
  33. 8.6.2 Merck KGaA Business Overview
  34. 8.6.3 Merck KGaA Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck KGaA Hormone Disorder Drug Product Portfolio
  36. 8.6.5 Merck KGaA Recent Developments
  37. 8.7 Lilly
  38. 8.7.1 Lilly Company Information
  39. 8.7.2 Lilly Business Overview
  40. 8.7.3 Lilly Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lilly Hormone Disorder Drug Product Portfolio
  42. 8.7.5 Lilly Recent Developments
  43. 8.8 Ferring B.V
  44. 8.8.1 Ferring B.V Company Information
  45. 8.8.2 Ferring B.V Business Overview
  46. 8.8.3 Ferring B.V Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ferring B.V Hormone Disorder Drug Product Portfolio
  48. 8.8.5 Ferring B.V Recent Developments
  49. 8.9 PT. Daewoong Pharmaceutical Company
  50. 8.9.1 PT. Daewoong Pharmaceutical Company Company Information
  51. 8.9.2 PT. Daewoong Pharmaceutical Company Business Overview
  52. 8.9.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Portfolio
  54. 8.9.5 PT. Daewoong Pharmaceutical Company Recent Developments
  55. 8.10 Mayne Pharma Group Limited
  56. 8.10.1 Mayne Pharma Group Limited Company Information
  57. 8.10.2 Mayne Pharma Group Limited Business Overview
  58. 8.10.3 Mayne Pharma Group Limited Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mayne Pharma Group Limited Hormone Disorder Drug Product Portfolio
  60. 8.10.5 Mayne Pharma Group Limited Recent Developments
  61. 8.11 Ipsen Pharma
  62. 8.11.1 Ipsen Pharma Company Information
  63. 8.11.2 Ipsen Pharma Business Overview
  64. 8.11.3 Ipsen Pharma Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ipsen Pharma Hormone Disorder Drug Product Portfolio
  66. 8.11.5 Ipsen Pharma Recent Developments
  67. 8.12 Genentech, Inc
  68. 8.12.1 Genentech, Inc Company Information
  69. 8.12.2 Genentech, Inc Business Overview
  70. 8.12.3 Genentech, Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech, Inc Hormone Disorder Drug Product Portfolio
  72. 8.12.5 Genentech, Inc Recent Developments
  73. 8.13 F. Hoffmann-La Roche Ltd
  74. 8.13.1 F. Hoffmann-La Roche Ltd Company Information
  75. 8.13.2 F. Hoffmann-La Roche Ltd Business Overview
  76. 8.13.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Portfolio
  78. 8.13.5 F. Hoffmann-La Roche Ltd Recent Developments
  79. 8.14 Bausch Health Companies Inc
  80. 8.14.1 Bausch Health Companies Inc Company Information
  81. 8.14.2 Bausch Health Companies Inc Business Overview
  82. 8.14.3 Bausch Health Companies Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Companies Inc Hormone Disorder Drug Product Portfolio
  84. 8.14.5 Bausch Health Companies Inc Recent Developments
  85. 8.15 Amneal Pharmaceutical Inc
  86. 8.15.1 Amneal Pharmaceutical Inc Company Information
  87. 8.15.2 Amneal Pharmaceutical Inc Business Overview
  88. 8.15.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Product Portfolio
  90. 8.15.5 Amneal Pharmaceutical Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hormone Disorder Drug Value Chain Analysis
  2. 9.1.1 Hormone Disorder Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hormone Disorder Drug Production Mode & Process
  6. 9.2 Hormone Disorder Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hormone Disorder Drug Distributors
  9. 9.2.3 Hormone Disorder Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst